← Back to headlines
Report Links Weight-Loss Drugs from Lilly and Novo to Stalling Cancer Growth
A new report suggests that weight-loss medications produced by pharmaceutical companies Lilly and Novo Nordisk may have an unexpected benefit, showing a link to the stalling of cancer progression.
22 May, 10:47 — 22 May, 10:47
Sources
Showing 1 of 1 sources
Related Stories
'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
Drilling Halted in Skammadal Due to Varmá River Pollution
2h ago
German Shorthaired Pointer Digs Incredible Tunnel System in Backyard
2h ago
Green Sea Turtle Sex Determination Linked to Pollution
2h ago